Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Safety Ratings 11,700+ NHTSA crash test ratings Investigations 5,300+ NHTSA defect investigations Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports Brand History Cross-category recall lookup by company
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases

Browse Drug Recalls

213 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 213 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 213 FDA drug recalls.

Clear
DateProductReasonClassFirm
Oct 13, 2015 Donnatal (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine H... Labeling: Not elsewhere classified - Product label incorrectly lists Scopolamine Hydrocodone as a... Class III Rx PAK
Jul 28, 2015 Health Mart Pharmacy loratadine orally disintegrating tablets, USP, 10 mg, 10... Superpotent Drug: Out Of Specification (OOS) result for Assay. Class III Ohm Laboratories, Inc.
Jul 28, 2015 Sunmark loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) ... Superpotent Drug: Out Of Specification (OOS) result for Assay. Class III Ohm Laboratories, Inc.
Dec 4, 2014 Eye Drops (Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the C... CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-... Class III K C Pharmaceuticals Inc
Dec 4, 2014 Eye Drops Advanced Relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povid... CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-... Class III K C Pharmaceuticals Inc
Sep 12, 2014 Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, R... Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled roo... Class II Mckesson
Jul 30, 2014 Alprazolam Tablets, USP 0.25 mg, UD 100 Tablets (10 x 10), Rx Only, Mfg By: S... Presence of Foreign Substance; tablets may contain stainless steel metal particulates Class II Mckesson Packaging Services
Jun 19, 2014 Aspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. ... Failed Dissolution Specification; at the 12 month time interval. Class III Mckesson Packaging Services
Mar 3, 2014 Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets ... Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval. Class III McKesson Packaging Services
Feb 7, 2014 Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephed... Defective Container: An unacceptable level of blister defects have been identified in Loratadine ... Class II Ohm Laboratories, Inc.
Nov 1, 2013 Acetaminophen suspension liquid, 160 mg/5 mL, cherry flavor, 2 FL OZ (59 mL) ... Defective Delivery System: There is a remote potential that cartons of product could be co-packag... Class II L. Perrigo Co.
Mar 29, 2012 buPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets... Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at th... Class III McKesson Packaging Services
Mar 29, 2012 buPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets... Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at th... Class III McKesson Packaging Services

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.